在乳腺癌腋窝淋巴结清扫术中应用腋窝反向映像技术的可行性与肿瘤学安全性

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (2541 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：研究在乳腺癌腋窝淋巴结清扫术中应用腋窝反向映像（ARM）技术的可行性与肿瘤学安全性。方法：选取30例乳腺癌改良根治术患者，应用亚甲蓝溶液进行术前注射染色定位淋巴结；在术中行腋窝淋巴结清扫时，切除蓝染淋巴结进行病理学检测。结果：30例乳腺癌患者中，21例患者成功检出蓝染的淋巴结，失败9例，检出蓝染淋巴结25枚，均未见明显癌转移。切除淋巴结的21例患者无一例出现上肢淋巴结水肿。结论：运用亚甲蓝溶液注射法进行ARM技术进行淋巴结追踪定位是可行的，且肿瘤负荷安全。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：腋窝反向映像技术, 乳腺肿瘤, 上肢水肿, 淋巴结切除术, 肿瘤学安全性

Abstract：Objective: To research the feasibility of axillary reverse mapping (ARM) in axillary lymph node dissection for breast cancer patients and the safety of the tumor. Methods: Thirty patients with modified radical mastectomy for breast cancer were treated with methylene blue solution for lymph node biopsy. The axillary lymph node dissection was performed and the lymph nodes were removed for histopathological examination. Results: The 30 patients with breast cancer, and 21 patients had successfully detected blue-stained lymph nodes, 9 cases had failed, and 25 had blue-stained lymph nodes. No obvious cancer metastasis was found. Excision of lymph nodes in 21 cases, no case of upper limb lymph node edema. Conclusion: It is feasible to carry out ARM using methylene blue solution injection method for lymph node tracing and localization, and the oncologically burden is safe.

Key words： axillary reverse mapping breast neoplasms upper extremity edema lymph node excision oncological safety

收稿日期: 2017-02-16

基金资助:浙江省医药卫生科技计划项目（2012KYA193，2013 KYB299）；丽水市科技计划项目（2010JYZB24，20110416）；丽水市高层次人才培养资助项目（2014RC11）。

通讯作者: 李校堃，教授，博士生导师，Email：wenzhoulxk@ 163.com

作者简介: 施勇（1975-），男，浙江缙云人，副主任医师，硕士生。

链接本文:

https://xb.wmu.edu.cn/CN/ 或 https://xb.wmu.edu.cn/CN/Y2017/V47/I11/801

[1] TUMMEL E, OCHOA D, KOROURIAN S, et al. Does axillary reverse mapping prevent lymphedema after lymphade-nectomy[J]. Ann Surg, 2017; 265(5): 987-992.
[2] JAGSI R, CHADHA M, MONI J, et al. Radiation field design in the ACOSOG Z0011 (Alliance) Trial[J]. J Clin Oncol, 2014, 32(32): 3600-3606.
[3] WILLIAMS A F, FRANKS P J, MOFFATT C J. Lymphoedema: estimating the size of the problem[J]. Palliat Med, 2005, 19(4): 300-313.
[4] MANSEL R E, FALLOWFIELD L, KISSIN M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial[J]. J Nat l Cancer Inst, 2006, 98(9): 599-609.
[5] BLANCHARD D K, DONOHUE J H, REYNOLDS C, et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer[J]. Arch Surg, 2003, 138(5): 482-487.
[6] NOGUCHI M, YAGASAKI R, KAWAHARA F, et al. Breast conserving treatment versus modified radical mastectomy in Japanese patients with operable breast cancer[J]. Int Surg, 1997, 82(3): 289-294.
[7] MORTON D L, WEN D R, WONG J H, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma[J]. Arch Surg, 1992, 127(4): 392-399.
[8] HSUEH E C, GIULIANO A E. Sentinel lymph node technique for staging of breast cancer[J]. Oncologist, 1998; 3(3): 165-170.
[9] THOMPSON M, KOROURIN S, HENRY-TILLMAN R,
et al. Axillary reverse mapping (ARM): A new concept to identify and enhance lymphatic preservation[J]. Ann Surg Oncol, 2007, 14(6): 1890-1895.
[10] BONETI C, KOROURIAN S, BLAND K, et al. Axillary reverse mapping:mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy[J]. J Am Coll Surg, 2008, 206(5): 1038-1042.
[11] BONETI C, KOROURIAN S, DIAZ Z, et al. Scientific Impact Award: axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymph-adenectomy[J]. Am J Surg, 2009, 198(4): 482-487.
[12] HAN J W, SEO Y J, CHOI J E, et al. The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer[J]. J Breast Cancer, 2012, 15(1): 91-97.
[13] AHMED R L, SCHMITZ K H, PRIZMENT A E, et al. Risk factors for lymphedema in breast cancer survivors, the lowa Women’s Health Study[J]. Breast Cancer Res Treat, 2011, 130(3): 981-991.
[14] KWAN M L, DARBIBIAN J, SCHMITZ K H, et al. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study[J]. Arch Surg, 2010, 145(11): 1055-1063.
[15] SHAH C, WILKINSON J B, BASCHNAGEL A, et al. Factors associated with the development of breast cancer-related lymphedema after whole breast irradiation[J]. Int J Radiat Oncol Biol Phys, 2012, 83(4): 1095-1100.
[16] HAYES S B, FREEDMAN G M, LI T, et al. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?[J]. Int J Radiat Oncol Biol Phys, 2008, 72(5): 1449-1455.
[17] PETREK J A, SENIE R T, PETERS M, et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after di-agnosis[J]. Cancer, 2001, 92(6): 1368-1377.
[18] KHAN S A. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept[J]. J Clin Oncol, 2009, 27(33): 5494-5496.
[19] 雷睿文, 欧林洋, 黄湛,等. 逆行腋窝淋巴结示踪术对预防乳腺癌术后上肢淋巴水肿的作用[J]. 广东医学, 2014, 35 (5): 704-707.
[20] KUMAR K S, HEMANTH G N, PANJWANI P K, et al. Feasibility of axillary reverse mapping and clinicopathological features predicting ARM node metastasis in breast cancer-a pilot study[J]. J Surg Oncol, 2017, 8(2): 119-122.
[21] RUBIO I T, CEBRECOS I, PEG V, et al. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast can-cer[J]. J Surg Oncol, 2012, 106(1): 89-93.
[22] NGUI N K, FRENCH J, KILDY C J, et al. Axillary reverse mapping in patients with breast cancer: Is it oncologically safe[J]. J Surg Oncol, 2016, 113(7): 726-731.
[23] GANDHI S J, SATISH C, SUNDARAM P S, et al. Feasibility study of axillary reverse mapping lymphoscintigraphy in carcinoma breast:A concept toward preventing lymphedema [J]. Indian J Nucl Med, 2016, 31(1): 9-13.
[24] BEEK M A, GOBARDHAN P D, KLOMPENHOUWER E G,
et al. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients[J]. Eur J Surg Oncol, 2015, 41(1): 59-63.
[25] OCHOA D, KORAURIAN S, BOETI C, et al. Axillary reverse mapping: five-year experience[J]. Surgery, 2014, 156 (5): 1261-1268.
[26] TAUSCH C, BAEGE A, DIETRICH D, et al. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients[J]. Eur J Surg Oncol, 2013, 39(8): 880-886.
[27] GEBRUERS N, TJALMA W A. Clinical feasibility of axillary reverse mapping and its influence on breast cancer related lymphedema: a systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 200: 117-122.
[28] PARKS R M, CHEUNG K L. Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy-A systematic review of the literature and necessity of a randomised study[J]. Breast, 2017, 33: 57-70.